<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31949271</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>16</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>428</StartPage><MedlinePgn>428</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">428</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-57366-y</ELocationID><Abstract><AbstractText>The present study aimed to investigate the prognostic importance of the neutrophil-to-lymphocyte ratio (NLR) in patients with amyotrophic lateral sclerosis (ALS). Among 322 patients diagnosed as having definite, probable, or possible ALS at a single tertiary hospital, 194 patients were included in the final analysis. Patients were divided into three groups (T1, T2, and T3) according to the tertile of their NLR. Survival rate was significantly lower in T3 compared to the other groups (log-rank test; T1 vs. T3, p&#x2009;=&#x2009;0.009; T2 vs. T3, p&#x2009;=&#x2009;0.008). Median survival duration was 37.0 (24.0-56.0), 32.5 (19.5-51.2), and 22.0 (17.0-38.0) months in T1, T2, and T3, respectively. In a multivariable Cox proportional hazards regression analysis, the hazard ratio of age at onset, bulbar-onset, and NLR (T3/T1) was 1.04 (1.02-1.06, p&#x2009;&lt;&#x2009;0.001), 1.68 (1.10-2.57, p&#x2009;=&#x2009;0.015), and 1.60 (1.01-2.51, p&#x2009;=&#x2009;0.041), respectively. A high baseline NLR may serve as a useful indicator for short survival duration in patients with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seok-Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Yoon-Ho</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0002-3325-6358</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sung-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Je-Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Young Ju</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0002-6816-8067</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Inha University School of Medicine, Incheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Jung-Joon</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea. jjsaint@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HI17C0200020019</GrantID><Agency>Korea Health Industry Development Institute (KHIDI)</Agency><Country>International</Country></Grant><Grant><GrantID>NRF-2019M3C7A1031867</GrantID><Agency>National Research Foundation of Korea (NRF)</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31949271</ArticleId><ArticleId IdType="pmc">PMC6965090</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-57366-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-57366-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/s1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/s1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson MP, et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS One. 2017;12:e0182002. doi: 10.1371/journal.pone.0182002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182002</ArticleId><ArticleId IdType="pmc">PMC5526569</ArticleId><ArticleId IdType="pubmed">28742871</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurol. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl Acad. Sci. USA. 2008;105:17913&#x2013;17918. doi: 10.1073/pnas.0804610105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes. JAMA Neurol. 2017;74:677&#x2013;685. doi: 10.1001/jamaneurol.2017.0357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0357</ArticleId><ArticleId IdType="pmc">PMC5822209</ArticleId><ArticleId IdType="pubmed">28437540</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, et al. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e242. doi: 10.1212/nxi.0000000000000242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Templeton AJ, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst. 2014;106:dju124. doi: 10.1093/jnci/dju124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/dju124</ArticleId><ArticleId IdType="pubmed">24875653</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentali F, et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature. Int. J. Cardiol. 2018;266:31&#x2013;37. doi: 10.1016/j.ijcard.2018.02.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.02.116</ArticleId><ArticleId IdType="pubmed">29887466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokgoz S, Keskin S, Kayrak M, Seyithanoglu A, Ogmegul A. Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume? J. Stroke Cerebrovasc. Dis. 2014;23:2163&#x2013;2168. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2014.04.007</ArticleId><ArticleId IdType="pubmed">25106834</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. J. Infect. 2019;78:339&#x2013;348. doi: 10.1016/j.jinf.2019.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2019.02.006</ArticleId><ArticleId IdType="pmc">PMC7173077</ArticleId><ArticleId IdType="pubmed">30802469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu ME, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer&#x2019;s disease. Dement. Geriatr. Cogn. Disord. 2012;34:69&#x2013;74. doi: 10.1159/000341583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000341583</ArticleId><ArticleId IdType="pubmed">22922667</ArticleId></ArticleIdList></Reference><Reference><Citation>Rembach A, et al. An increased neutrophil-lymphocyte ratio in Alzheimer&#x2019;s disease is a function of age and is weakly correlated with neocortical amyloid accumulation. J. Neuroimmunol. 2014;273:65&#x2013;71. doi: 10.1016/j.jneuroim.2014.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.05.005</ArticleId><ArticleId IdType="pubmed">24907904</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C, et al. Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2017;74:660&#x2013;667. doi: 10.1001/jamaneurol.2016.6179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.6179</ArticleId><ArticleId IdType="pmc">PMC5822215</ArticleId><ArticleId IdType="pubmed">28384752</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 2001;74:328&#x2013;334. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R, et al. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One. 2008;3:e2740. doi: 10.1371/journal.pone.0002740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002740</ArticleId><ArticleId IdType="pmc">PMC2481277</ArticleId><ArticleId IdType="pubmed">18648532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol. 2014;71:1134&#x2013;1142. doi: 10.1001/jamaneurol.2014.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Keizman D, et al. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta neurologica Scandinavica. 2009;119:383&#x2013;389. doi: 10.1111/j.1600-0404.2008.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2008.01112.x</ArticleId><ArticleId IdType="pubmed">18976328</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SJ. Tissue destruction by neutrophils. N. Engl. J. Med. 1989;320:365&#x2013;376. doi: 10.1056/nejm198902093200606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm198902093200606</ArticleId><ArticleId IdType="pubmed">2536474</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Sanberg PR. Blood-CNS Barrier Impairment in ALS patients versus an animal model. Front. Cell Neurosci. 2014;8:21. doi: 10.3389/fncel.2014.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00021</ArticleId><ArticleId IdType="pmc">PMC3910123</ArticleId><ArticleId IdType="pubmed">24550780</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield TA, Best TM, Merrick MA. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J. Athl. Train. 2006;41:457&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1748424</ArticleId><ArticleId IdType="pubmed">17273473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CF, Moalem-Taylor G. Detailed characterization of neuro-immune responses following neuropathic injury in mice. Brain Res. 2011;1405:95&#x2013;108. doi: 10.1016/j.brainres.2011.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.06.022</ArticleId><ArticleId IdType="pubmed">21741621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurimoto T, et al. Neutrophils express oncomodulin and promote optic nerve regeneration. J. Neurosci. 2013;33:14816&#x2013;14824. doi: 10.1523/jneurosci.5511-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.5511-12.2013</ArticleId><ArticleId IdType="pmc">PMC3771038</ArticleId><ArticleId IdType="pubmed">24027282</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 1993;50:30&#x2013;36. doi: 10.1001/archneur.1993.00540010026013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1993.00540010026013</ArticleId><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten KG, Beers DR, Zhao W, Appel SH. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:364&#x2013;375. doi: 10.1007/s13311-014-0329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0329-3</ArticleId><ArticleId IdType="pmc">PMC4404435</ArticleId><ArticleId IdType="pubmed">25567201</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiathan R, et al. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Immunobiology. 2014;219:487&#x2013;496. doi: 10.1016/j.imbio.2014.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2014.02.010</ArticleId><ArticleId IdType="pubmed">24661720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Med. (Baltim.) 2018;97:e11138. doi: 10.1097/md.0000000000011138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000011138</ArticleId><ArticleId IdType="pmc">PMC6039688</ArticleId><ArticleId IdType="pubmed">29952958</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/s1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JH, et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:1311.e1317&#x2013;1319. doi: 10.1016/j.neurobiolaging.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.004</ArticleId><ArticleId IdType="pubmed">23088937</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>